Product Code: GVR-1-68038-881-7
The global protein purification and isolation market size is expected to reach USD 11.2 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 8.3% over the forecast period. Increase in technological advancements and investments for the development of structure-based drugs by both private and public research organizations are driving the demand for protein purification and isolation products.
Rising demand for the development of single-use products for purification due to increasing need to classify novel protein-based ligands with high specificity and improved proteomics research are further driving market growth. Another factor driving the adoption rate of protein purification techniques is the availability of an extensive range of innovative resins for various applications.
The key players operating in the market are Merck KGaA; Thermo Fisher Scientific; Qiagen; Sigma-Aldrich Co.; GE Healthcare; Agilent Technologies; Bio-Rad Laboratories, Inc.; Norgen Biotek Corporation; Abcam plc, and Promega Corporation. Market players are adopting strategies such as expansion of product portfolio through R&D initiatives, mergers, acquisitions, and strategic collaborations to further strengthen their position in the market.
Further key findings from the report suggest:
- The reagents segment is estimated to register a significant growth rate over the forecast period. This is attributed to its high usage in cell lysis and increased commercialization of advanced resins
- On the basis of technology,chromatography emerged as the leading segment in 2019 owing to the availability of a varied range of products, enhanced results for complex protein purification, and high reliability
- Drug screening is estimated to be the fastest-growing application segment over the forecast period owing to factors such as high efficacy and increasing R&D investments by manufacturers for the screening of novel drugs
- Contract research organizations (CROs) are projected to witness a significant growth rate over the forecast period. This is attributed to increasing R&D investments and growing number of preclinical trials outsourced by drug development firms
- North America dominated the global protein purification and isolation market in 2019 owing to factors such as established research infrastructure, presence of major players, and technological advancements in the region
Asia Pacific is estimated to register the highest CAGR over the forecast period due to increasing economic stability, growing number of CROs, and R&D activities in academic and research institutes.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Research Methodology
- 1.2 Research Assumptions
- 1.2.1 Estimates and Forecast Timeline
- 1.3 Research Methodology
- 1.4 Information Procurement
- 1.4.1 Purchased Database
- 1.4.2 GVR's Internal Database
- 1.4.3 Secondary Sources
- 1.4.4 Primary Research
- 1.4.5 Details of Primary Research
- 1.5 Information or Data Analysis
- 1.5.1 Data Analysis Models
- 1.6 Market Formulation & Validation
- 1.7 Model Details
- 1.7.1 Commodity Flow Analysis
- 1.7.1.1 Approach 1: Commodity Flow Approach
- 1.7.1.2 Approach 2: Country wise market estimation using bottom up approach
- 1.8 Global Market: CAGR Calculation
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1:
- 1.11.2 Objective 2:
- 1.12 List of Tables
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
Chapter 4 Industry Outlook
- 4.1 Market Variable Analysis
- 4.1.1 Increase in investment in pharmaceutical and biotechnological R&D
- 4.1.2 Growing need for more accurate and rapid purification kits
- 4.1.3 Technological advancements
- 4.2 Market Restraint Analysis
- 4.2.1 High cost of purification instruments and lack of skilled professionals
- 4.3 Penetration and Growth Prospect Mapping
- 4.4 Regulatory Framework
- 4.4.1 Standards & compliances
- 4.5 Protein Purification and Isolation Market Analysis Tools
- 4.5.1 PESTEL Analysis
- 4.5.1.1 Political landscape
- 4.5.1.2 Environmental landscape
- 4.5.1.3 Social landscape
- 4.5.1.4 Technology landscape
- 4.5.1.5 Legal landscape
- 4.5.2 Industry analysis - Porter's
- 4.5.2.1 Supplier power (Moderate due to requirement of high-quality raw materials)
- 4.5.2.2 Buyer power (Moderate due to increasing demand for novel technologies)
- 4.5.2.3 Substitution threat (Low due to to the accuracy requirements of the products)
- 4.5.2.4 New entrants' threat (High due to to increasing number of companies)
- 4.5.2.5 Competitive rivalry (High due to the market is fragemented)
- 4.5.3 Major deals & strategic alliances analysis
- 4.5.3.1 Joint ventures
- 4.5.3.2 Mergers & acquisitions
- 4.5.3.3 Licensing & partnership
- 4.5.3.4 Technology collaborations
- 4.5.3.5 Strategic divestments
Chapter 5 Competitive Analysis
- 5.1 Recent Developments & Impact Analysis, by Key Market Participants
- 5.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
- 5.3 Vendor Landscape
- 5.3.1 List of key distributors
- 5.3.2 Key company market share analysis
- 5.4 Public Companies
- 5.4.1 Company market position analysis
- 5.4.2 Competitive dashboard analysis
- 5.5 Private Companies
- 5.5.1 List of key emerging companies /technology disruptors/innovators
- 5.5.2 Regional network map
Chapter 6 Products Business Analysis
- 6.1 Protein Purification and Isolation Market: Products Movement Analysis
- 6.2 Instruments
- 6.2.1 Instruments market estimates and forecast, 2016 - 2027
- 6.3 Consumables
- 6.3.1 Consumables market estimates and forecast, 2016 - 2027
- 6.3.2 Kits
- 6.3.2.1 Kits market estimates and forecast, 2016 - 2027
- 6.3.3 Reagents
- 6.3.3.1 Reagents market estimates and forecast, 2016 - 2027
- 6.3.4 Columns
- 6.3.4.1 Columns market estimates and forecast, 2016 - 2027
- 6.3.5 Magnetic beads
- 6.3.5.1 Magnetic beads market estimates and forecast, 2016 - 2027
- 6.3.6 Resins
- 6.3.6.1 Resins market estimates and forecast, 2016 - 2027
- 6.3.7 Others
- 6.3.7.1 Others market estimates and forecast, 2016 - 2027
Chapter 7 Technology Business Analysis
- 7.1 Protein Purification and Isolation Market: Technology Movement Analysis
- 7.2 Ultrafiltration
- 7.2.1 Ultrafiltration market estimates and forecast, 2016 - 2027
- 7.3 Precipitation
- 7.3.1 Precipitation market estimates and forecast, 2016 - 2027
- 7.4 Chromatography
- 7.4.1 Chromatography market estimates and forecast, 2016 - 2027
- 7.4.2 Ion exchange chromatography
- 7.4.2.1 Ion exchange chromatography market estimates and forecast, 2016 - 2027
- 7.4.3 Affinity Chromatography
- 7.4.3.1 Affinity chromatography market estimates and forecast, 2016 - 2027
- 7.4.4 Reversed phase chromatography
- 7.4.5 Reversed phase chromatography market estimates and forecast, 2016 - 2027
- 7.4.6 Size exclusion chromatography
- 7.4.7 Size exclusion chromatography market estimates and forecast, 2016 - 2027
- 7.4.8 Hydrophobic interaction chromatography (HIC)
- 7.4.9 Hydrophobic interaction chromatography market estimates and forecast, 2016 - 2027
- 7.5 Electrophoresis
- 7.5.1 Electrophoresis market estimates and forecast, 2016 - 2027
- 7.5.2 Gel electrophoresis
- 7.5.3 Gel electrophoresis market estimates and forecast, 2016 - 2027
- 7.5.4 Isoelectric focusing (IEF)
- 7.5.5 Isoelectric focusing (IEF) market estimates and forecast, 2016 - 2027
- 7.5.6 Capillary electrophoresis
- 7.5.7 Capillary electrophoresis market estimates and forecast, 2016 - 2027
- 7.6 Western Blotting
- 7.6.1 Western Blotting market estimates and forecast, 2016 - 2027
- 7.7 Others
- 7.7.1 Others market estimates and forecast, 2016 - 2027
Chapter 8 Application Business Analysis
- 8.1 Protein Purification and Isolation Market: Application Movement Analysis
- 8.2 Drug Screening
- 8.2.1 Drug screening market estimates and forecast, 2016 - 2027
- 8.3 Biomarker Discovery
- 8.3.1 Biomarker Discovery market estimates and forecast, 2016 - 2027
- 8.4 Protein-protein interaction studies
- 8.4.1 Protein-protein interaction studies market estimates and forecast, 2016 - 2027
- 8.5 Diagnostics
- 8.5.1 Diagnostics market estimates and forecast, 2016 - 2027
Chapter 9 End Use Business Analysis
- 9.1 Protein Purification and Isolation Market: End Use Movement Analysis
- 9.2 Academic and Research Institutes
- 9.2.1 Academic and research institutes market estimates and forecast, 2016 - 2027
- 9.3 Hospitals
- 9.3.1 Hospitals Market estimates and forecast, 2016 - 2027
- 9.4 Pharmaceutical and Biotechnological Companies
- 9.4.1 Pharmaceutical and Biotechnological companies Market estimates and forecast, 2016 - 2027
- 9.5 CROs
- 9.5.1 CRO Market estimates and forecast, 2016 - 2027
Chapter 10 Regional Business Analysis
- 10.1 Protein Purification and Isolation Market: Regional Movement Analysis
- 10.2 North America
- 10.2.1 North America, SWOT analysis
- 10.2.2 North America market estimates and forecast, 2016 - 2027
- 10.2.3 U.S.
- 10.2.3.1 U.S. market estimates and forecast, 2016 - 2027
- 10.2.4 Canada
- 10.2.4.1 Canada market estimates and forecast, 2016 - 2027
- 10.3 Europe
- 10.3.1 Europe, SWOT analysis
- 10.3.2 Europe market estimates and forecast, 2016 - 2027
- 10.3.3 Germany
- 10.3.3.1 Germany market estimates and forecast, 2016 - 2027
- 10.3.4 U.K.
- 10.3.4.1 U.K. market estimates and forecast, 2016 - 2027
- 10.3.5 France
- 10.3.5.1 France market estimates and forecast, 2016 - 2027
- 10.3.6 Spain
- 10.3.6.1 Spain market estimates and forecast, 2016 - 2027
- 10.3.7 Italy
- 10.3.7.1 Italy market estimates and forecast, 2016 - 2027
- 10.4 Asia Pacific
- 10.4.1 Asia Pacific, SWOT analysis
- 10.4.2 Asia Pacific market estimates and forecast, 2016 - 2027
- 10.4.3 Japan
- 10.4.3.1 Japan market estimates and forecast, 2016 - 2027
- 10.4.4 China
- 10.4.4.1 China market estimates and forecast, 2016 - 2027
- 10.4.5 India
- 10.4.5.1 India market estimates and forecast, 2016 - 2027
- 10.4.6 South Korea
- 10.4.6.1 South Korea market estimates and forecast, 2016 - 2027
- 10.5 Latin America
- 10.5.1 Latin America, SWOT analysis
- 10.5.2 Latin America market estimates and forecast, 2016 - 2027
- 10.5.3 Brazil
- 10.5.3.1 Brazil market estimates and forecast, 2016 - 2027
- 10.5.4 Mexico
- 10.5.4.1 Mexico market estimates and forecast, 2016 - 2027
- 10.5.5 Colombia
- 10.5.5.1 Colombia market estimates and forecast, 2016 - 2027
- 10.5.6 Chile
- 10.5.6.1 Chile market estimates and forecast, 2016 - 2027
- 10.6 MEA
- 10.6.1 MEA, SWOT analysis
- 10.6.2 MEA market estimates and forecast, 2016 - 2027
- 10.6.3 South Africa
- 10.6.3.1 South Africa market estimates and forecast, 2016 - 2027
- 10.6.4 UAE
- 10.6.4.1 UAE market estimates and forecast, 2016 - 2027
Chapter 11 Company Profiles
- 11.1 Company Profiles
- 11.1.1 Thermo Fischer Scientific Inc.
- 11.1.1.1 Company overview
- 11.1.1.2 Financial performance
- 11.1.1.3 Product benchmarking
- 11.1.1.4 Strategic initiatives
- 11.1.2 Merck KGaA
- 11.1.2.1 Company overview
- 11.1.2.2 Sigma-Aldrich Corporation
- 11.1.2.2.1 Company overview
- 11.1.2.3 Financial performance
- 11.1.2.4 Product benchmarking
- 11.1.2.5 Strategic Initiatives
- 11.1.3 QIAGEN
- 11.1.3.1 Company overview
- 11.1.3.2 Financial performance
- 11.1.3.3 Product benchmarking
- 11.1.3.4 Strategic Initiatives
- 11.1.4 Bio-Rad Laboratories, Inc.
- 11.1.4.1 Company overview
- 11.1.4.2 Financial performance
- 11.1.4.3 Product benchmarking
- 11.1.4.4 Strategic Initiatives
- 11.1.5 Agilent Technologies
- 11.1.5.1 Company overview
- 11.1.5.2 Financial performance
- 11.1.5.3 Product benchmarking
- 11.1.5.4 Strategic initiatives
- 11.1.6 Promega Corporation
- 11.1.6.1 Company Overview
- 11.1.6.2 Product benchmarking
- 11.1.6.3 Strategic initiatives
- 11.1.7 General Electric Company
- 11.1.7.1 Company overview
- 11.1.7.2 Financial performance
- 11.1.7.3 Product benchmarking
- 11.1.7.4 Strategic initiatives
- 11.1.8 Norgen Biotek Corp.
- 11.1.8.1 Company overview
- 11.1.8.2 Product benchmarking
- 11.1.9 Abcam plc
- 11.1.9.1 Company overview
- 11.1.9.2 Financial performance
- 11.1.9.3 Product benchmarking
- 11.1.9.4 Strategic initiatives
比較リスト
